FOR IMMEDIATE RELEASE
CONTACT: Amber Hamilton
OUTPATIENT SOLUTIONS FOR JOINT REPLACEMENT PATIENTS
OFFERED TO AMBULATORY SURGERY CENTERS NATIONWIDE BY DEPUY SYNTHES COMPANIES
New Program Designed to Facilitate Best Practices, Better Outcomes,
Efficiencies and Higher Patient Satisfaction
WARSAW, IN – November 10, 2015 – DePuy Synthes Companies announces the national launch of the DEPUY SYNTHES ADVANTAGE™ Outpatient Solutions Program to facilitate best practices and protocols for joint replacement in ambulatory surgical centers (ASCs) and outpatient hospitals throughout the United States.
“Outpatient joint replacement is an emerging option for healthy, motivated patients that may help them safely recover more quickly, and in the comfort of their own homes, instead of in the hospital,” said Scott Zellner, Director, DEPUY SYNTHES ADVANTAGE. “When performed on the right patient, in the right setting, with trained staff, and leveraging innovative surgical techniques and implant technologies, these procedures have the potential to improve outcomes, speed recovery, manage costs, improve efficiency and increase patient satisfaction.”
Through the DEPUY SYNTHES ADVANTAGE Outpatient Solutions Program, DePuy Synthes Joint Reconstruction* offers a comprehensive hip, knee, and shoulder portfolio of orthopaedic surgical products alongside a suite of innovative education, training, and professional and patient support services designed specifically for outpatient settings. Education and team-based training covers patient selection and prep, operating procedures, pre- and post-op care, discharge management, patient monitoring, physical therapy and patient engagement. Since piloting the program, the team has trained more than 500 health care professionals.
DEPUY SYNTHES ADVANTAGE Outpatient Solutions also includes subscription-based software called CareSense for data collection and analysis, and the PATIENT ATHLETE™ Program, a video-based patient empowerment program that utilizes similar science-based tools and techniques developed by the Johnson & Johnson Human Performance Institute for top athletes, surgeons and CEOs.
“Outpatient surgery is evolving into another layer of our healthcare model where patients are now requesting these outpatient procedures that are more value based with the goals of better outcomes, less complications and faster recovery periods,” said Mark Gittins**, D.O., New Albany Surgical Center, New Albany, Ohio. “In our Ambulatory Surgery Center we have implemented programs from DEPUY SYNTHES ADVANTAGE such as CareSense, Patient Ambassador and surgical tray optimization, which have helped to create additional efficiencies in our center and patients certainly benefit from this new era of care.”
Outpatient joint replacement is a growing trend driven by less-invasive surgical techniques, better pain management techniques, improved recovery and rehabilitation protocols, and patients who want to return home as soon as possible.  However, experts say these outpatient procedures still represent a small percentage of the more than 1 million knee and hip replacements performed each year in the United States. 
“As an industry leader in orthopaedics, we have an opportunity to support adoption of outpatient joint replacement through proven and comprehensive programs that go beyond the implant with the goals of improving clinical outcomes, increasing patient satisfaction and reducing costs,” said Zellner. “We expect more health care professionals will consider outpatient joint replacement as an important option for their patients, and we will be right there with them to provide the support they need to optimize outcomes.”
DEPUY SYNTHES ADVANTAGE Programs: CareSense and PATIENT ATHLETE Program
Data collection and patient engagement play a particularly important role in an outpatient setting and DePuy Synthes Companies is offering ASCs two important fee-based tools as part of its outpatient solutions to help in data collection and patient engagement.
CareSense enables health care providers and facilities to collect and analyze real-time data on patient outcomes, patient satisfaction and costs before, during and after surgery, to help optimize care. The system makes it easy to conduct market research, administer satisfaction surveys, benchmark against peers, and analyze financial metrics.
While CareSense focuses on data collection and analysis, the Patient Athlete Program is a self-guided, video-based training program that focuses on wellness and the overall patient experience to help joint, trauma and spine patients prepare for surgery and emerge afterwards stronger and healthier in both mind and spirit. The program has been successfully piloted in four cities and a survey of these patients found that more than half (55%) of them felt they recovered more quickly and were less fearful of surgery because of the program.
About DePuy Synthes Companies
DePuy Synthes Companies of Johnson & Johnson provides the most comprehensive orthopaedic and neurological solutions in the world. The company offers an unparalleled breadth of products, services, programs and research and development capabilities. DePuy Synthes Companies’ solutions in the specialties of joint reconstruction, trauma, neurological, craniomaxillofacial, spinal surgery and sports medicine are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information visit, www.depuysynthes.com .
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding the new DEPUY SYNTHES ADVANTAGE Outpatient Solutions Program. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of DePuy Orthopaedics, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; competition, including technological advances, new products and patents attained by competitors; changes to applicable laws and regulations, including global health care reforms; and changes in behavior and spending patterns or financial distress of purchasers of health care products and services. A further list and description of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended December 28, 2014, including in Exhibit 99 thereto, and the company’s subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov , www.jnj.com or on request from Johnson & Johnson. None of the DePuy Synthes Companies nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.
©DePuy Synthes 2015. All rights reserved.
*A division of DePuy Orthopaedics, Inc.
**Consultant for DePuy Synthes Companies of Johnson & Johnson
 Henderson RA, Watters TS, Godin JA, Mather III RC, Berend KR, Bolognesi MP. Outpatient joint arthroplasty is increasing in the United States. Presented at: American Academy of Orthopaedic Surgeons (AAOS) 2015 Annual Meeting; March 24-28, 2015; Las Vegas, NV. E-poster P165-2015.
 Department of Research & Scientific Affairs, American Academy of Orthopaedic Surgeons. Annual Incidence of Common Musculoskeletal Procedures and Treatment. http://www.aaos.org/research/stats/CommonProceduresTreatments-March2014.pdf . Published March 2014. Accessed Sept. 2015.